Mirago-S 50 Tablet is a combination medicine used to treat overactive bladder (OAB) with symptoms of urinary incontinence (urine leakage), urgent or frequent urination, increased night-time urination, and dysuria (painful or difficult urination). Overactive bladder is a condition in which there is a problem with bladder function, which causes a sudden urge to urinate that might be difficult to control.
 
Mirago-S 50 Tablet contains Solifenacin (anti-cholinergic) and Mirabegron (beta-3 adrenergic agonist). Solifenacin reduces the undesirable contractions of the bladder, thereby increasing the amount of urine that the bladder can hold. This decreases the urgency for urination. Mirabegron relaxes the muscles of the bladder; this prevents frequent, uncontrolled, or urgent urination. Together, Mirago-S 50 Tablet helps in treating overactive bladder.
 
You are advised to take Mirago-S 50 Tablet for as long as your doctor has prescribed it for you, depending on your medical condition. In some cases, you may experience common side-effects such as dry mouth, constipation, headache, high blood pressure, and vomiting. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
 
Consult your doctor if you are pregnant or breastfeeding. Mirago-S 50 Tablet is not recommended for children as safety and efficacy have not been established. Mirago-S 50 Tablet may cause blurred vision, so drive with caution. Avoid or limit alcohol consumption along with Mirago-S 50 Tablet as it could lead to increased dizziness. Inform your doctor about your health condition and medications before taking Mirago-S 50 Tablet to rule out any side effects/interactions.

Mirago-S 50 Tablet is a combination of two drugs, namely: Solifenacin and Mirabegron. Mirago-S 50 Tablet is a combination medicine used to treat overactive bladder (OAB) with symptoms of urinary incontinence (urine leakage), urgent or frequent urination, increased night-time urination, dysuria (painful or difficult urination). Solifenacin is an anti-cholinergic that reduces the undesirable contractions of the bladder, thereby increasing the amount of urine that the bladder can hold. This decreases the urgency for urination. Mirabegron is a beta-3 adrenergic agonist which relaxes the muscles of the bladder; this prevents frequent, uncontrolled, or urgent urination. Together, Mirago-S 50 Tablet helps in treating an overactive bladder.

Do not take Mirago-S 50 Tablet if you are allergic to any of its contents. Inform your doctor if you have glaucoma, myasthenia gravis, ulcerative colitis, urinary retention, high blood pressure, angioedema, kidney or liver problems. Consult your doctor if you are pregnant or breastfeeding. Mirago-S 50 Tablet is not recommended for children. Mirago-S 50 Tablet may cause blurred vision, so drive with caution. Avoid or limit alcohol consumption with Mirago-S 50 Tablet as it could lead to increased dizziness.